Literature DB >> 2658360

Dilation therapy of benign esophageal stenoses.

G N Tytgat.   

Abstract

Benign esophageal obstruction is virtually always responsive to dilation therapy. Dilation therapy should, therefore, be the initial approach. The introduction of the Savary-type dilating equipment and of balloon dilation systems are, or will become, standard practice. These systems will increasingly be preferred over the Eder-Puestow metal olives and the mercury-filled bougies in the near future, although the latter 2 will retain some distinct indications. All currently available dilating devices have advantages and shortcomings. The overall symptomatic and objective success rate of dilation therapy is acceptable. Perforation remains the major complication. Nonsurgical therapy of perforation is possible provided perforation site has occurred. Future controlled comparative studies are perforation site has occurred. Future controlled comparative studies are required to determine the usefulness and efficacy of the various dilation systems.

Entities:  

Mesh:

Year:  1989        PMID: 2658360     DOI: 10.1007/bf01658390

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  23 in total

1.  Complications associated with esophagogastroduodenoscopy and with esophageal dilation.

Authors:  P Mandelstam; C Sugawa; S E Silvis; O T Nebel; B H Rogers
Journal:  Gastrointest Endosc       Date:  1976-08       Impact factor: 9.427

2.  Esophageal dilatation using the Eder Puestow dilators.

Authors:  C M Royston; B L Dowling; M W Gear
Journal:  Am J Surg       Date:  1976-06       Impact factor: 2.565

3.  A safer method of dilating oesophageal strictures.

Authors:  J D Price; C Stanciu; J R Bennett
Journal:  Lancet       Date:  1974-06-08       Impact factor: 79.321

4.  Natural history of benign esophageal stricture treated by dilatation.

Authors:  D J Patterson; D Y Graham; J L Smith; J T Schwartz; E Alpert; F L Lanza; G D Cain
Journal:  Gastroenterology       Date:  1983-08       Impact factor: 22.682

5.  Bougienage is effective therapy for most benign esophageal strictures.

Authors:  F L Lanza; D Y Graham
Journal:  JAMA       Date:  1978-09-01       Impact factor: 56.272

6.  Comparison of the Eder-Puestow and Celestin techniques for dilating benign oesophageal strictures.

Authors:  K R Hine; C J Hawkey; M Atkinson; G K Holmes
Journal:  Gut       Date:  1984-10       Impact factor: 23.059

7.  A new method of esophageal dilation using Savary-Gilliard bougies.

Authors:  J F Dumon; B Meric; M V Sivak; D Fleischer
Journal:  Gastrointest Endosc       Date:  1985-12       Impact factor: 9.427

8.  Dilatation of severe esophageal strictures by an inflatable balloon catheter.

Authors:  R L London; B W Trotman; A J DiMarino; J A Oleaga; D B Freiman; E J Ring; E F Rosato
Journal:  Gastroenterology       Date:  1981-01       Impact factor: 22.682

9.  Eder--Puestow oesophageal dilatation: a new hazard.

Authors:  C J Sanderson; G A Trotter
Journal:  Br J Surg       Date:  1980-04       Impact factor: 6.939

Review 10.  Hydrostatic balloon dilation of gastrointestinal stenoses: a national survey.

Authors:  R A Kozarek
Journal:  Gastrointest Endosc       Date:  1986-02       Impact factor: 9.427

View more
  5 in total

1.  Quality of life after surgery for benign oesophageal stricture.

Authors:  J R Bennett; C M Royston
Journal:  BMJ       Date:  1990-02-10

2.  Radiologically guided balloon dilatation of obstructing gastrointestinal strictures.

Authors:  M M McNicholas; R G Gibney; D P MacErlaine
Journal:  Abdom Imaging       Date:  1994 Mar-Apr

Review 3.  The value of endoscopy and endosonography in the diagnosis of the dysphagic patient.

Authors:  R Lorenz; G Jorysz; M Classen
Journal:  Dysphagia       Date:  1993       Impact factor: 3.438

4.  NSAIDs-Related Pyloroduodenal Obstruction and Its Endoscopic Management.

Authors:  Mohd Talha Noor; Pankaj Dixit; Rakesh Kochhar; Birinder Nagi; Usha Dutta; Kartar Singh; Kuchhangi Suresh Poornachandra
Journal:  Diagn Ther Endosc       Date:  2011-06-06

5.  Clinical implications of endoscopic ultrasonography non-traversability in patients with locoregional esophageal cancer receiving multimodality therapy.

Authors:  Charles J Cho; Ho June Song; Gin Hyug Lee; Kee Don Choi; Yong-Hee Kim; Jin-Sook Ryu; Sung-Bae Kim; Jong Hoon Kim; Seung-Il Park; Hwoon-Yong Jung
Journal:  Korean J Intern Med       Date:  2016-03-14       Impact factor: 2.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.